Breakfast Symposia

Sponsored breakfast symposia are available to registered delegates to attend at no additional cost, and will be held during the programme.

Once an event is live you can indicate your interest in attending any of the Industry Breakfast Symposia*.

 *(You can also use this link to add clinical skills sessions to your original registration!).

*past events*

Thursday 5 July 2018
08.00-09.00 (breakfast available 07.30-08.00)

Session 29
Because sound matters – sponsored by Oticon Medical




This symposium covered the latest clinical results and developments of the Oticon Medical implantable systems, including the Neuro cochlear implant system and the Ponto bone anchored system.

Three talks focused on cochlear implants and the Neuro system. Mr. Anirvan Banerjee gave an update on the experience with the Neuro Zti implant. The latest clinical results from a clinical trial of the Neuro 2 sound processor, showing among many other positives excellent speech-in-noise performance, were presented by Dr Dan Gnansia. Ms. Rupan Banga. They gave an update on the benefits of treating the older cochlear implant patients.

For bone anchored devices, Ms Ann-Louise McDermott presented the long-term results of children treated with bone anchored implants, and how the results have improved over time with refined surgical techniques and implant technologies. Understanding patients and supporting the professionals are two of our key values. Based on research and together with professionals, Oticon Medical has developed new tools to help in the important pre-operative evaluation period. These tools, gave us a glimpse into future bone anchored technologies, which was presented by Mr. Marcus Holmberg.

For full details please click here

Session 30
Immuno-Oncology: What do we need to know? – sponsored by Bristol-Myers Squibb




Immunotherapy harnesses the patients own immune system to kill cancer cells. In this hour meeting we asked experts to explain the different approaches employed and the evidence that has been generated to support practice change.

Immunotherapy is NICE approved for treating head and neck cancer patients. We learnt which patients can be given immunotherapy, and who is likely to benefit from it. We also heard about new strategies being investigated to tip the balance in favour of the patient, using tobacco plants to treat cancer!

For full details please click here

Session 31
Early intervention in CRS and ETD…What does this look like and what do we do next? sponsored by Entellus Medical




We held an exciting discussion with peers to explore how current technology is allowing for earlier intervention among sinusitis and Eustachian tube dysfunction patients.

For full details please click here

Session 32
Narrow Band Imaging: cords in the spotlight at last? – sponsored by Olympus

This session explored the utility of Narrow Band imaging in the outpatient and intraoperative setting, in the management of laryngeal pathology. The evidence base on this technique has burgeoned significantly and was debated at length.

For full details please click here